Complex treatment of uveitis with macular edema associated with systemic diseases using autologous platelet-rich plasma

2021 ◽  
pp. 148-152
Author(s):  
N.S. Arbenyeva ◽  
◽  
V.I. Bratko ◽  
A.N. Trunov ◽  
V.V. Chernykh ◽  
...  
Keyword(s):  
Macular Edema ◽  
Comparison Group ◽  
Platelet Rich Plasma ◽  
Ophthalmological Examination ◽  
Systemic Diseases ◽  
Complex Treatment ◽  
Autologous Plasma ◽  
Autologous Platelet Rich Plasma ◽  
Anti Inflammatory ◽  
Autologous Platelet

In patients with uveitis associated with systemic diseases, a common cause of low vision is macular edema, which develops at any localization of the inflammatory process in 38–84% of cases. Autologous platelet-rich plasma is widely used in various branches of medicine, however, in the treatment of uveitis accompanied by macular edema, the clinical efficacy of its use has not been sufficiently studied. Purpose. To conduct a clinical and laboratory assessment of the effectiveness of complex treatment of uveitis with macular edema associated with systemic diseases using autologous platelet-rich plasma. Material and methods. The study included 120 people (120 eyes) from 18 to 50 years old with uveitis and macular edema associated with systemic diseases: 51 men, 69 women. Patients were divided into 2 groups: the main group consisted of patients who received anti-inflammatory treatment and administration of autologous plasma platelet-rich; comparison group – patients who received anti-inflammatory treatment. All patients underwent a comprehensive ophthalmological examination. Results. It has been established that the administration of autologous platelet-rich plasma against the background of anti-inflammatory treatment in patients with uveitis associated with systemic diseases accompanied by macular edema improves the maximally corrected visual acuity, a statistically significant decrease in the thickness of the retina in the fovea and an increase in the light sensitivity of the retina, relative to the data obtained in the comparison group. Conclusion. The use of autologous platelet-rich plasma in combination with anti-inflammatory treatment leads to a decrease in the incidence of recurrence of uveitis associated with systemic diseases, helps to reduce macular edema and improve functional parameters. Key words: uveitis, macular edema, anti-inflammatory treatment, autologous platelet-rich plasma.

scholarly journals Comprehensive Treatment of Noninfectious Uveitis Accompanied by Macular Edema with the Use of Autologous Platelet-Rich Plasma

2019 ◽  
Vol 4 (4) ◽  
pp. 83-90
Author(s):  
N. S. Arbenyeva ◽  
V. I. Bratko ◽  
A. N. Trunov ◽  
G. V. Bratko ◽  
V. V. Chernykh
Keyword(s):  
Visual Acuity ◽  
Macular Edema ◽  
Platelet Rich Plasma ◽  
Federal State ◽  
Comprehensive Treatment ◽  
Complex Treatment ◽  
Infectious Uveitis ◽  
Autologous Platelet Rich Plasma ◽  
Anti Inflammatory ◽  
Autologous Platelet

Background. A common cause of visual impairment in patients with non-infectious uveitis is macular edema, developing in 38–84 % of cases. Plasma enriched with platelets is widely used in various branches of medicine, the effectiveness of its use in the treatment of non-infectious uveitis, accompanied by macular edema, has not been sufficiently investigated. Aim: To evaluate the effectiveness of autologous platelet-rich plasma in the complex treatment of non-infectious uveitis accompanied by macular edema.Material and methods. The study was conducted on the basis of the academician S.N. Fyodorov Eye Microsurgery Federal State Institution in the period from 2016 to 2018, which included 123 people (176 eyes) from 18 to 50 years with non-infectious uveitis, accompanied by macular edema: 46 men, 77 women. Patients were divided into 2 groups. The main group consisted of patients receiving autologous platelet-rich plasma and anti-inflammatory treatment; the comparison group consisted of patients receiving anti-inflammatory treatment. The results of visual acuity, intraocular pressure, biomicroophthalmoscopy, optical coherence tomography of the macular zone, microperimetry, ultrasound examination on the side of the affected eye were evaluated. Statistical processing of the data was carried out in the program Statistica 10.Results. Maintenance of autologous platelet-rich plasma contributes to a statistically significant improvement in visual acuity on the 10th day of treatment by 64.2 %, a decrease in the thickness of the retina in fovea by 36.3 % and an increase in retinal photosensitivity by 34.6 % compared to the group of patients receiving only anti-inflammatory treatment. Conclusions. The use of autologous platelet-rich plasma in the complex treatment of non-infectious uveitis allows to accelerate the natural mechanisms of tissue regeneration, contributing to the reduction of macular edema, and improve visual performance.

scholarly journals REPARATIVE PROCESSES FEATURES IN TROPHIC ULCERS CAUSED BY DIABETES MELLITUS WITH THE USE OF PLATELET-RICH PLASMA

2020 ◽  
Vol 73 (10) ◽  
pp. 2150-2155
Author(s):  
Igor D. Duzhiy ◽  
Andrii S. Nikolaienko ◽  
Vasyl M. Popadynets ◽  
Oleksandr V. Kravets ◽  
Igor Y. Hresko ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Growth Factors ◽  
Comparison Group ◽  
Platelet Rich Plasma ◽  
Main Group ◽  
Lower Limbs ◽  
Before And After ◽  
Autologous Platelet Rich Plasma ◽  
Inflammatory Changes ◽  
Autologous Platelet

The aim: Was following: the improvement of the treatment results of the lower limbs ulcers, caused by the diabetes mellitus by using our technique of the platelet-rich plasma application; the study of the features of the morphological and immunohistochemical changes, and the effect of the growth factors of the platelet-rich plasma on the regeneration and healing of the ulcers. Materials and methods: 38 patients with the trophic ulcers of the lower limbs, caused by diabetes mellitus were involved in the study. To assess the morphological features of the reparative processes before and after the treatment with PRP, the histological and immunohystochemical studies of the biopsy specimen of ulcers were carried out. Results: The total epithelialization of the ulcers in the patients from the main group was achieved on 46.5 day, and in the comparison group – 81.7 day. The light and optical study of the specimen of the main group, using the autologous platelet-rich plasma revealed the elimination of the destructive changes and reduction of the mixed-cellular infiltration compared to the patients from the comparison group. The immunohystochemical study revealed the increase of the growth factors receptors. Conclusions: The usage of the autologous platelet-rich plasma in the treatment of the trophic ulcers results in the rapid regeneration by the decrease of the destructive and inflammatory changes as well as the improvement of the vascularization.

scholarly journals Autologous platelet-rich plasma combined with hyaluronic acid is a new method of minimally invasive treatment of stress urinary incontinence in women

2018 ◽  
pp. 16-20
Author(s):  
I. A. Apolikhina ◽  
A. V. Sokolova ◽  
A. S. Saidova ◽  
E. A. Gorbunova
Keyword(s):  
Urinary Incontinence ◽  
Hyaluronic Acid ◽  
Stress Urinary Incontinence ◽  
Platelet Rich Plasma ◽  
Physiological Mechanism ◽  
Common Disease ◽  
Invasive Treatment ◽  
Autologous Plasma ◽  
Autologous Platelet Rich Plasma ◽  
Autologous Platelet

Stress urinary incontinence (SUI) is a common disease. It is 2 times more common among women than in men. The causes of SUI are the insufficiency of the closing function of the sphincter of the bladder and/or hypermobility of the urethra. For this reason, methods aimed at improving the closing function of the urethra, i.e., the use of volume-forming agents are justified for the treatment of this disease. Side effects and time-limited relief of symptoms of urinary incontinence after the application of volumeforming agents, or at the other hand complications after surgery lead to the search for alternative treatments that can restore the natural physiological mechanism of urinary retention. This study demonstrates that administration of platelet-rich autologous plasma in combination with hyaluronic acid in the periurethral region is a safe and effective method of treatment of SUI in women.

CASE REPORT: SUBCONJUNCTIVAL INJECTION WITH AUTOLOGOUS PLATELET-RICH PLASMA FOR REFRACTORY CORNEAL ULCERS IN A DOG

2018 ◽  
Vol 44 (04) ◽  
pp. 211-216
Author(s):  
Shu-Fang Yang ◽  
Heng-Leng Yang ◽  
Sao-Ling Liang ◽  
Peng-Chen Wang
Keyword(s):  
Platelet Rich Plasma ◽  
Corneal Edema ◽  
Tissue Growth ◽  
Autologous Serum ◽  
Subconjunctival Injection ◽  
Ophthalmological Examination ◽  
Intact Male ◽  
Corneal Ulcers ◽  
Autologous Platelet Rich Plasma ◽  
Autologous Platelet

A 12-year-old, intact, male Golden Retriever dog presented with a 1-month history of corneal ulcer, redness, and occasional squint in the left eye (oculus sinister [OS]). A thorough ophthalmological examination revealed corneal edema, diffuse corneal vascularization, and excessive granulation tissue growth. The tentative diagnosis was chronic superficial keratitis or pannus. After 3 weeks of treatment for OS, blepharospasm and superficial corneal ulceration with a lip of nonadherent epithelium of the right eye (oculus dexter [OD]) developed. No improvement was observed after autologous serum eye drop treatment combined with simple debridement and grid keratotomy on both eyes (oculi uterque [OU]) for 3 months; thereafter, blindness developed. The diagnosis was refractory corneal ulcers. The application of autologous platelet-rich plasma (PRP) was instilled via subconjunctival injection OU every 2 weeks for 2 months. The OU corneas started to re-epithelialize and heal, and the granulation tissues significantly decreased while the vision improved. Therefore, PRP was continued to be administered every 1–2 months for 6 months. After more than 1 year, the OU corneas have healed without recurrent ulceration and with only mild haze. In conclusion, autologous PRP subconjunctival injection is a potentially beneficial addition to the medical management of refractory corneal ulcers in dogs.

Autologous platelet-rich plasma for assisted reproduction

2021 ◽  
Author(s):  
Dennis Vaidakis ◽  
Eleni Sertedaki ◽  
Vasilios Karageorgiou ◽  
Charalampos S Siristatidis
Keyword(s):  
Assisted Reproduction ◽  
Platelet Rich Plasma ◽  
Autologous Platelet Rich Plasma ◽  
Autologous Platelet
Sign in / Sign up

Export Citation Format

Share Document